Skip to main content
SpringerLink
Log in

Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2

  • Research Article
  • Published:
Tumor Biology

Abstract

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies worldwide. Androgen receptor (AR) plays an important role in many kinds of cancers. However, the molecular mechanisms of AR in ESCC are poorly characterized. In the present study, Western blot analysis and real-time quantitative PCR were performed to identify differentially expressed AR in 40 ESCC tissue samples, which revealed that the messenger RNA (mRNA) and protein expression of AR is upregulated in the ESCC tissue samples. AR overexpression induced increases in ESCC cell invasion and proliferation in vitro. Silencing of AR inhibited the proliferation of KYSE450 cells which have a relatively high level of AR, and the invasion of KYSE450 cells was distinctly suppressed. Furthermore, AR knockdown led to substantial reductions in matrix metalloproteinase 2 (MMP2) and p-AKT levels in ESCC cell lines, but no significant change in AKT and MMP9 expression. These results suggest that AR is involved in tumor progression, and thus, AR could represent selective targets for the molecularly targeted treatments of ESCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.

    Article  CAS  PubMed  Google Scholar 

  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    Article  CAS  PubMed  Google Scholar 

  3. Chai J, Jamal MM. Esophageal malignancy: a growing concern. World J Gastroenterol. 2012;18:6521–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, et al. Predictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol. 2001;96:2839–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer. 2001;95:92–5.

    Article  CAS  PubMed  Google Scholar 

  6. Rosato A, Pivetta M, Parenti A, Iaderosa GA, Zoso A, et al. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer. 2006;119:1717–22.

    Article  CAS  PubMed  Google Scholar 

  7. Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC, Chen CL, et al. Androgen pathway stimulates microRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis. Hepatology. 2012;56(2):632–43.

    Article  CAS  PubMed  Google Scholar 

  8. Ha S, Ruoff R, Kahoud N, Franke TF, Logan SK. Androgen receptor levels are upregulated by Akt in prostate cancer. Endocr Relat Cancer. 2011;18(2):245–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ou Y, Liu L, Xue L, Zhou W, Zhao Z, Xu B, et al. TRAP1 shows clinical significance and promotes cellular migration and invasion through STAT3/MMP2 pathway in human esophageal squamous cell cancer. J Genet Genomics. 2014;41(10):529–37.

    Article  PubMed  Google Scholar 

  10. Uraoka N, Oue N, Sakamoto N, Sentani K, Oo HZ, Naito Y, et al. NRD1, which encodes nardilysin protein, promotes esophageal cancer cell invasion through induction of MMP2 and MMP3 expression. Cancer Sci. 2014;105(1):134–40.

    Article  CAS  PubMed  Google Scholar 

  11. Balk SP. Androgen receptor as a target in androgen-independent prostate cancer. Urology. 2002;60 Suppl 1:132–9.

    Article  PubMed  Google Scholar 

  12. Zhang BG, Du T, Zang MD, Chang Q, Fan ZY, Li JF, et al. Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9. Oncotarget. 2014;5(21):10584–95.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer. 2014;21(3):R165–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Slattery ML, Sweeney C, Murtaugh M, Ma KN, Caan BJ, Potter JD, et al. Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer. Int J Cancer. 2006;118(12):3140–6.

    Article  CAS  PubMed  Google Scholar 

  15. Yerramilli-Rao P, Garofalo O, Whatley S, Leigh PN, Gallo JM. Androgen-controlled specific gene expression in neuroblastoma cells. J Neurol Sci. 1995;129(Suppl):131–5.

    Article  CAS  PubMed  Google Scholar 

  16. Tihan T, Harmon JW, Wan X, Younes Z, Nass P, Duncan KL, et al. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus. Anticancer Res. 2001;21(4B):3107–14.

    CAS  PubMed  Google Scholar 

  17. Yamashita Y, Hirai T, Mukaida H, Kawano K, Toge T, Niimoto M, et al. Detection of androgen receptors in human esophageal cancer. Jpn J Surg. 1989;19(2):195–202.

    Article  CAS  PubMed  Google Scholar 

  18. Matsuoka H, Sugimachi K, Ueo H, Kuwano H, Nakano S, Nakayama M. Sex hormone response of a newly established squamous cell line derived from clinical esophageal carcinoma. Cancer Res. 1987;47(15):4134–40.

    CAS  PubMed  Google Scholar 

  19. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was funded by the grant “Experimental Study of the Splenic Artery Targeted Removal of Activated T Cells to Inhibit Acute Rejection”, 2012FFB03401, longitudinal support project by the Science and Technology Department of Hubei Province.

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Surgery, The Third Affiliated Hospital of Jianghan University, Wuhan, China

    Yi Zhang & Xiaoxuan Zhong

  2. Division of Cardiothoracic Surgery, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Ave., Wuhan, 430030, China

    Tiecheng Pan, Xiaoxuan Zhong & Cai Cheng

Authors
  1. Yi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tiecheng Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaoxuan Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cai Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cai Cheng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, Y., Pan, T., Zhong, X. et al. Androgen receptor promotes esophageal cancer cell migration and proliferation via matrix metalloproteinase 2. Tumor Biol. 36, 5859–5864 (2015). https://doi.org/10.1007/s13277-015-3257-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3257-x

Keyword

Search

Navigation